Skip to main content
Important Update Actualización importante:

Good news! All CHIP, STAR, and STAR Kids Member Handbooks are now available online. Quick, easy access to your benefits and coverage information - any time!

¡Buenas noticias! Todos los manuales para miembros de CHIP, STAR y STAR Kids ya están disponibles en línea. Obtén acceso rápido y sencillo a la información sobre tus beneficios y cobertura, ¡en cualquier momento!

Medicaid Preferred Drug List and Formulary Changes Cambios en el formulario y la lista de medicamentos preferidos de Medicaid

The Vendor Drug Program (VDP) made changes to the Texas Medicaid drug formulary effective July 24, 2026. To learn more about formulary changes impacted, please click here for more information.

El programa de medicamentos de proveedores de Texas (VDP) ha realizado cambios recientes en el formulario de medicamentos de Medicaid de Texas. Esto entrará en vigencia el 24 de julio de 2026. Para obtener más información sobre los cambios en el formulario afectados, visite el siguiente enlace para obtener más información.

Texas Medicaid Prior Authorization Updates for Diabetic Equipment and Supplies 2025

Date: September 19, 2025

Attention: Providers

Effective for dates of service on or after November 1, 2025

Call to action: The purpose of this communication is to inform providers that effective for dates of service on or after November 1, 2025, Texas Medicaid will update prior authorization criteria for diabetic equipment and supplies.

How this impacts providers: Prior Authorization for Rental of External Insulin Pumps

To meet prior authorization criteria for rental of external insulin pumps, clients diagnosed with type 1 or type 2 diabetes must:

  • Receive multiple daily administrations of insulin.
  • Meet at least two of the following criteria:
    • Elevated glycosylated hemoglobin level (HbA1c) over 7.0 percent
    • History of dawn phenomenon or Somogyi phenomenon with fasting blood sugars frequently exceeding 200 mg/dl
    • History of severe glycemic excursions with wide fluctuations in blood glucose
    • History of problematic hypoglycemia (less than 60 mg/dL) with or without hypoglycemic unawareness
    • Anticipation of pregnancy within three months

Prior Authorization for Continuous Glucose Monitors (CGMs)

For initial prior authorization of a CGM, the treating practitioner must have an in-person or Medicaid-approved telemedicine visit with the client within six months before ordering a monitor to:

  • Evaluate the client’s diabetes control.
  • Determine that the client meets the prior authorization criteria for a CGM.

Refer to the current Texas Medicaid Provider Procedures Manual, Durable Medical Equipment, Medical Supplies, and Nutritional Products Handbook, subsection 2.2.12.7.1, “Prior Authorization,” for prior authorization criteria.

Continued Coverage Requirements
For continued CGM coverage, the treating practitioner must have an in-person or Medicaid-approved telemedicine health visit with the client every six months following the initial prescription of the CGM to document that the client adheres to the CGM regimen and diabetes treatment plan.

Next step for Providers: Providers should share this communication with their staff.

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org

For access to all provider alerts: www.texaschildrenshealthplan.org/provideralerts.